Thomas Köhnke
10PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Nov 20, 2025
DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency.Thomas Köhnke, Daiki Karigane, Eleanor Hilgart
|Oct 30, 2025
Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML.Daiki Karigane, Amy C Fan, Toshinobu Nishimura
|Jul 15, 2025
<i>ASXL1</i> truncating mutations drive leukemic resistance to T cell attack.Dustin McCurry, Zhongqi Ge, Jaehyun Lee
|Nov 18, 2024
DNMT3A<sup>R882H</sup> Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency.Thomas Köhnke, Daiki Karigane, Eleanor Hilgart
|Feb 15, 2024
Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119.Thomas Köhnke, Kevin A Nuno, Catherine C Alder
|Jan 23, 2024
IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation.Niklas Landberg, Thomas Köhnke, Yang Feng
Pageof 2
Frequent Collaborators
7 joint publications
Ravindra Majeti
6 joint publications
Amy C Fan
5 joint publications
Yusuke Nakauchi
4 joint publications
Daiki Karigane
4 joint publications
Niklas Landberg
3 joint publications
Yang Feng
3 joint publications
Daniel Thomas
3 joint publications
Miles H Linde
3 joint publications
Melissa Stafford
3 joint publications
Kelly Lim
